4 results  1 of 1 

1 Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis
Ying Lin, Mingxi Lin, Jian Zhang, Biyun Wang, Zhonghua Tao, Yiqun Du, Sheng Zhang, Jun Cao, Leiping Wang, Xichun Hu
Cancer Res Treat.2020;52(4):1059-1066.   Published online 2020 April 24     DOI: http://dx.doi.org/10.4143/crt.2019.633
      
2 BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy
Sung-Bae Kim, In-Gu Do, Janice Tsang, Tae-You Kim, Yoon-Sim Yap, Gerardo Cornelio, Gyungyub Gong, Soonmyung Paik, Suee Lee, Ting-Ying Ng, Sarah Park, Ho-Suk Oh, Joanne Chiu, Joohyuk Sohn, Moonhee Lee, Young-Jin Choi, Eun Mi Lee, Kyong-Hwa Park, Christos Nathaniel, Jungsil Ro
Cancer Res Treat.2019;51(4):1527-1539.   Published online 2019 June 4     DOI: http://dx.doi.org/10.4143/crt.2018.598
      
3 FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation
Jinju Park, Yiseul Choi, Young San Ko, Younghoon Kim, Jung-Soo Pyo, Bo Gun Jang, Min A Kim, Jae-Seon Lee, Mee Soo Chang, Jong-Wan Park, Byung Lan Lee
Cancer Res Treat.2018;50(1):239-254.   Published online 2017 March 24     DOI: http://dx.doi.org/10.4143/crt.2016.580
      
4 Long-term Complete Response with Lapatinib Plus Capecitabine in a Patient with HER2-Positive Breast Cancer Metastasized to the Pancreas
Kichul Shin, Jinsu Kim, Seokyoung Yoon, Eung-Ho Cho, Changwon Jung, Hye Jin Kang
Ewha Med J.2015;38(3):138-143.   Published online 2015 October 31     DOI: http://dx.doi.org/10.12771/emj.2015.38.3.138
      

 1 of 1